How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials

Molecular Psychiatry
S LeuchtJohn M Davis

Abstract

We conducted a systematic review and meta-analysis of randomized controlled trials that compared second-generation antipsychotic (SGA) drugs with placebo in schizophrenic patients and which considered 13 different outcome measures. Thirty-eight randomized controlled trials with 7323 participants were included. All SGA drugs were more effective than placebo, but the pooled effect size (ES) for overall symptoms (primary outcome) was moderate (-0.51). The absolute difference (RD) in responder rates was at 18% (41% responded to drug compared with 24% to placebo, number needed to treat=6). Similar ESs were found for the other efficacy parameters: negative symptoms (ES=-0.39), positive symptoms (ES=-0.48), depression (ES=-0.26), relapse (RD 20%) and discontinuation due to inefficacy (RD 17%). Curiously, the efficacy of haloperidol for negative and depressive symptoms was similar to that of the SGA drugs. In contrast to haloperidol, there was no difference in terms of EPS between any SGA drugs and placebo, and there was also no difference in terms of dropouts due to adverse events. Meta-regression showed a decline in treatment response over time, and a funnel plot suggested the possibility of publication bias. We conclude that the dru...Continue Reading

Associated Clinical Trials

References

Sep 1, 1978·Archives of General Psychiatry·T Van Putten, R P May
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Dec 1, 1969·Computers and Biomedical Research, an International Journal·M L Cohen
Jan 1, 1970·Acta Psychiatrica Scandinavica. Supplementum·G M Simpson, J W Angus
Jun 1, 1994·The American Journal of Psychiatry·S R Marder, R C Meibach
Jan 1, 1995·The American Journal of Psychiatry·M L Paillère-MartinotF Aubin
Mar 1, 1995·Archives of General Psychiatry·R J Baldessarini, A C Viguera
Jan 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·P BoyerF Aubin
May 1, 1996·The British Journal of Psychiatry. Supplement·S R HirschL A Arvanitis
Feb 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C M BeasleyS Hamilton
Mar 1, 1996·Psychopharmacology·C M BeasleyS Hamilton
Jan 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·H LooO Fleurot
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Apr 8, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·D G DanielM Lakshminarayanan
Dec 6, 2000·Journal of Clinical Psychopharmacology·A HoferW W Fleischhacker
Apr 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jeffrey A LiebermanRobert M Hamer
Jun 11, 2003·Archives of General Psychiatry·John M DavisIra D Glick
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Mar 1, 1964·Archives of General Psychiatry·N J COLEC H BRANCH
Nov 19, 2003·Journal of Clinical Psychopharmacology·Charles M BeasleyUNKNOWN Olanzapine Relapse Prevention Study Group
Nov 25, 2003·The Journal of Clinical Psychiatry·Teresa A PigottUNKNOWN Aripiprazole Study Group
Dec 9, 2003·The Journal of Clinical Psychiatry·Ya-Mei BaiChao-Cheng Lin
Mar 17, 2004·Biological Psychiatry·Mark H CorriganUNKNOWN Sonepiprazole Study Group
Apr 20, 2004·British Journal of Clinical Pharmacology·Bernard M Y CheungCyrus R Kumana
Nov 19, 2004·European Archives of Psychiatry and Clinical Neuroscience·M RiedelH-J Möller
Dec 23, 2004·Journal of Clinical Epidemiology·Thomas A TrikalinosUNKNOWN EU-PSI project
Jul 16, 2005·BMJ : British Medical Journal·Joanna Moncrieff, Irving Kirsch
Jul 22, 2005·The New England Journal of Medicine·Joann G Elmore, Gerd Gigerenzer
Jul 30, 2005·European Journal of Clinical Nutrition·C D SummerbellJ J van Binsbergen
Aug 27, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Stefan Leucht, Rolf R Engel
Sep 13, 2005·Biological Psychiatry·Paul G SurteesJonathan Flint

❮ Previous
Next ❯

Citations

Aug 21, 2012·Psychopharmacology·Masaaki OgasaJohn Guarino
Nov 23, 2011·European Archives of Psychiatry and Clinical Neuroscience·Hans-Jürgen Möller
Feb 20, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Simon FreyTom Stargardt
Oct 29, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ayşegül YildizRoss J Baldessarini
Feb 1, 2008·Schizophrenia Bulletin·Stefan LeuchtJohn M Kane
Mar 13, 2008·Schizophrenia Bulletin·John M Davis, Stefan Leucht
Nov 22, 2011·Schizophrenia Bulletin·John M KanePhilip Szeszko
Jan 24, 2013·Therapeutic Advances in Chronic Disease·Erik Johnsen, Rune A Kroken
Aug 15, 2013·Annals of General Psychiatry·Konstantinos N FountoulakisHans-Jürgen Möller
Oct 21, 2009·PLoS Medicine·Mari Jair de JesusGraham Thornicroft
Jun 10, 2011·Neuropsychiatric Disease and Treatment·Leslie Citrome
Oct 7, 2010·The Journal of Clinical Psychiatry·John M Kane, Christoph U Correll
Apr 1, 2011·The Journal of Clinical Psychiatry·Andrew C Leon
Oct 17, 2013·Indian Journal of Pharmacology·Siddharth Sarkar, Sandeep Grover
Apr 3, 2014·Schizophrenia Research and Treatment·Martin WiesjahnTania M Lincoln
Feb 5, 2014·Schizophrenia Bulletin·Stefan LeuchtJohn M Davis
Jan 5, 2013·Behavioural and Cognitive Psychotherapy·Paul HuttonAdrian Wells
Nov 5, 2013·Schizophrenia Research·Steffen MoritzDaniela Roesch-Ely
Jul 30, 2014·Psychological Medicine·N SanfordT S Woodward
Sep 14, 2014·Asian Journal of Psychiatry·Dawn BruijnzeelRajiv Tandon
Feb 3, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Stefan LeuchtJohn M Davis
Aug 4, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Anthony P MorrisonDouglas Turkington
Mar 15, 2012·Current Psychiatry Reports·Rune Andreas Kroken, Erik Johnsen
Feb 26, 2014·Journal of Medical Economics·Jean LachaineMaud Beillat
Oct 13, 2012·International Review of Psychiatry·Ary GadelhaJair de Jesus Mari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here